Trump accuses Dems of playing ‘con game’ with Kavanaugh nomination delays, investigations

Do Dems have a double standard when it comes to Kavanaugh? Democratic strategist Jason Nichols and Matthew Swift, chairman of Concord 51 PAC, join the debate. President Trump on Tuesday accused Democrats of playing a "con game" with their calls for delays and investigations over sexual misconduct claims against Supreme Court nominee Brett Kavanaugh. "It’s horrible what the Democrats have […]

Read more

Feinstein, other Dems largely silent on abuse claims against Keith Ellison

Are Democrats ignoring Keith Ellison's accuser? Karen Monahan claims to have been smeared, threatened and isolated from the Democratic Party. As top Democrats speak out on sexual misconduct claims against Supreme Court nominee Judge Brett Kavanaugh, they’ve been largely silent on physical and verbal harassment claims against one of their own: Rep. Keith Ellison, a top Democratic National Committee (DNC) official. Sen. Dianne […]

Read more

Dems press Kavanaugh on abortion, Kozinski harassment allegations in second day of raucous hearings

Senate Judiciary Committee holds hearing for Brett Kavanaugh Confirmation hearing for Kavanaugh to join U.S. Supreme Court. Senate Democrats aggressively questioned Judge Brett Kavanaugh about his previous rulings on abortion, executive power, and gun rights on Wednesday, the second day of confirmation hearings marked by persistent interruptions from protesters and thinly veiled suggestions that the Supreme Court nominee was not […]

Read more

Ex-Novartis CEO pitched Michael Cohen on lower drug prices, Senate Dems say

Michael Cohen’s book deal may get scrapped: Gasparino FBN’s Charlie Gasparino discusses how former Trump attorney Michael Cohen may lose a book deal over the Stormy Daniels controversy. Michael Cohen, President Donald Trump’s former personal attorney, extensively communicated with pharmaceutical giant Novartis as the firm sought access to Trump administration officials in hopes of influencing healthcare policy on drug pricing, […]

Read more
1 7 8 9